Noncytolytic control of viral infections by the innate and adaptive immune response.
By L. Guidotti, F. Chisari. Annual Review of Immunology, 2001
1,077 citations recorded by the source corpus.
Subfields: Epidemiology, Immunology
View Paper: https://www.semanticscholar.org/paper/7585ffcbe4659c8e12b385c8f13d8c2c36ecc13c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Immunology
Citations in the corpus
- Adenovirus Infections in Immunocompetent and Immunocompromised Patients (2014, background): “Moreover, innate effector cells, particularly natural killer cells, which can destroy virus-infected cells in a nonspecific fashion, are recruited and activated (104, 113).”
- Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 (2001, background): “Viral infection of mammalian cells results in activation of an innate immune response mediated by type I IFNs, IFN-α and IFN-β, and other cytokines, including interleukin (IL)-6 and IL-12 (refs&nbs”
- Adoptive-cell-transfer therapy for the treatment of patients with cancer (2003, background): “cgi?l=8743">TRAIL )) and cytotoxic degranulation, which leads to perforinmediated lysi”
- Immunobiology and pathogenesis of viral hepatitis. (2006, background): “Like innate immune cells described above, these T cells participate in viral pathogenesis either directly (by killing infected cells) or indirectly (by producing soluble factors such as cytokines and chemokines) that contribute to the inflammatory process and/or inhibit viral replication (1, 94).”
- Occult hepatitis B virus infection. (2007, background): “In fact, there is evidence indicating that cytokines like tumor necrosis factor a and interferon c may strongly inhibit the HBV gene expression at post-transcriptional level [37,38].”
- Viruses and interferon: a fight for supremacy (2002, background): “Both class-I-restricted CD8 + T cells and class-II-restricted CD4 + T cells are activated during viral infectio”